Generic Name and Formulations:
Mebendazole 100mg; chew tabs.
Impax Laboratories, Inc.
Indications for EMVERM:
Enterobiasis (pinworm). Trichuriasis (whipworm). Ascariasis (common roundworm). Uncinariasis (common or American hookworm).
Adults and Children:
Chew, swallow or crush and mix with food. Enterobiasis: 100mg as a single dose. Other parasites: 100mg AM and PM for 3 consecutive days. May repeat after 3 weeks.
Periodically assess organ system functions including hematopoietic and hepatic during prolonged therapy. Children <2 years. Pregnancy (Cat.C): not recommended (esp. during 1st trimester). Nursing mothers.
May be potentiated by cimetidine.
Abdominal pain, diarrhea; rare: hypersensitivity reactions, convulsions, neutropenia, agranulocytosis, hepatitis.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Erdafitinib Granted FDA Breakthrough Therapy Designation for Urothelial Carcinoma
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- Confronting Racial Disparities in Prostate Cancer Survival Outcomes
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- NSCLC: Pretreatment Weight Loss May Be Linked to Socioeconomic Status
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC